Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Investing Profile

Bali Muralidhar

InvestorVC
Managing Partner at Abingworth
Abingworth Managing Partner
$15.0M - $30.0M
$22.5M
12
$465M
CompanyStageDateRound SizeTotal Raised
Glycomine
Series CApr 2025$120M
Series BJun 2021$35M
$150M
Co-investors: Dominic Schmidt (Advent Life Sciences), Jim Trenkle (Sanofi Ventures), Niall O’Donnell (RiverVest)
AdvanCell
Series CFeb 2025$110M
$110M
Co-investors: Jamil Beg (5am Ventures), Christopher Gagliardi (Sanofi Ventures)
Ascend Gene & Cell Therapies
Series AMay 2023$66M
$66M
Anjarium Biosciences
Series ASep 2021$60M
$60M
CymaBay Therapeutics
Post Ipo DebtAug 2021$100M
$190M
Co-investors: Andrew Schwab (5am Ventures), Tony Evnin (Venrock)
Wugen
Series BJul 2021$170M
$170M
Co-investors: John McKearn (RiverVest)
Reneo Pharmaceuticals
Series BDec 2020$95M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest)
NuCana BioMed
Post Ipo EquityOct 2020$80M
$140M
Co-investors: James Healy (Sofinnova Investments)